Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kaehler

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
European Journal of Pharmacology|April 22, 1993
Indomethacin reduces substance P levels in human ocular aqueous humorG Kieselbach, J Troger, C Kaehler, et al.
Melanoma Research|June 11, 2009
Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patientKatharina C Kaehler, Friederike Egberts, Paul Lorigan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 28, 2009
Pegylated interferons: prospects for the use in the adjuvant and palliative therapy of metastatic melanomaKatharina C Kaehler, Vernon K Sondak, Dirk Schadendorf, et al.
Anticancer Research|July 2, 2010
Serum S100B and LDH are not useful in predicting the sentinel node status in melanoma patientsFriederike Egberts, Annika Momkvist, Jan-Hendrik Egberts, et al.
Seminars in Oncology|November 16, 2010
Update on immunologic therapy with anti-CTLA-4 antibodies in melanoma: identification of clinical and biological response patterns, immune-related adverse events, and their managementKatharina C Kaehler, Sarah Piel, Elisabeth Livingstone, et al.
Journal of the American Academy of Dermatology|February 9, 2008
Multiple skin metastases of malignant melanoma with unusual clinical and histopathologic features in an immunosuppressed patientFriederike Egberts, Katharina C Kaehler, Jochen Brasch, et al.
Onkologie|July 4, 2008
Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDHFriederike Egberts, Andrea Pollex, Jan-Hendrik Egberts, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 19, 2010
Clinicopathologic prognostic markers of survival: an analysis of 259 patients with malignant melanoma >or=1 mmFriederike Egberts, A Momkvist, J H Egberts, et al.
Melanoma Research|April 29, 2015
Novel DNA methylation markers with potential prognostic relevance in advanced malignant melanoma identified using COBRA assaysKatharina C Kaehler, Oliver Politz, David Henderson, et al.
Melanoma Research|November 18, 2008
Melanocytic schwannoma of the cutaneous and subcutaneous tissues: three cases and a review of the literatureKatharina C Kaehler, Paul A J Russo, Detlef Katenkamp, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
European Journal of Pharmacology|April 22, 1993
Indomethacin reduces substance P levels in human ocular aqueous humorG Kieselbach, J Troger, C Kaehler, et al.
Melanoma Research|June 11, 2009
Anti-CTLA-4 therapy-related autoimmune hypophysitis in a melanoma patientKatharina C Kaehler, Friederike Egberts, Paul Lorigan, et al.
European Journal of Cancer (Oxford, England : 1990)|October 28, 2009
Pegylated interferons: prospects for the use in the adjuvant and palliative therapy of metastatic melanomaKatharina C Kaehler, Vernon K Sondak, Dirk Schadendorf, et al.
Anticancer Research|July 2, 2010
Serum S100B and LDH are not useful in predicting the sentinel node status in melanoma patientsFriederike Egberts, Annika Momkvist, Jan-Hendrik Egberts, et al.
Seminars in Oncology|November 16, 2010
Update on immunologic therapy with anti-CTLA-4 antibodies in melanoma: identification of clinical and biological response patterns, immune-related adverse events, and their managementKatharina C Kaehler, Sarah Piel, Elisabeth Livingstone, et al.
Journal of the American Academy of Dermatology|February 9, 2008
Multiple skin metastases of malignant melanoma with unusual clinical and histopathologic features in an immunosuppressed patientFriederike Egberts, Katharina C Kaehler, Jochen Brasch, et al.
Onkologie|July 4, 2008
Long-term survival analysis in metastatic melanoma: serum S100B is an independent prognostic marker and superior to LDHFriederike Egberts, Andrea Pollex, Jan-Hendrik Egberts, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 19, 2010
Clinicopathologic prognostic markers of survival: an analysis of 259 patients with malignant melanoma >or=1 mmFriederike Egberts, A Momkvist, J H Egberts, et al.
Melanoma Research|April 29, 2015
Novel DNA methylation markers with potential prognostic relevance in advanced malignant melanoma identified using COBRA assaysKatharina C Kaehler, Oliver Politz, David Henderson, et al.
Melanoma Research|November 18, 2008
Melanocytic schwannoma of the cutaneous and subcutaneous tissues: three cases and a review of the literatureKatharina C Kaehler, Paul A J Russo, Detlef Katenkamp, et al.
Pageof 3